Affiliations 

  • 1 School of Biosciences, Taylor's University, Lakeside Campus, Subang Jaya, Malaysia
  • 2 Institute of Ocean and Earth Sciences, University of Malaya, Kuala Lumpur, Malaysia
  • 3 British Antarctic Survey, NERC, Cambridge, United Kingdom
  • 4 Biofunctional Molecule Exploratory Research Group (BMEX), School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
  • 5 School of Biological Sciences, Monash University, Clayton, VIC, Australia
Front Pharmacol, 2020;11:1086.
PMID: 32848730 DOI: 10.3389/fphar.2020.01086

Abstract

The skin is the first line of defense against pathogen and other environmental pollutant. The body is constantly exposed to reactive oxygen species (ROS) that stimulates inflammatory process in the skin. Many studies have linked ROS to various inflammatory skin diseases. Patients with skin diseases face various challenges with inefficient and inappropriate treatment in managing skin diseases. Overproduction of ROS in the body will result in oxidative stress which will lead to various cellular damage and alter normal cell function. Multiple signaling pathways are seen to have significant effects during ROS-mediated oxidative stress. In this review, microalgae have been selected as a source of natural-derived antioxidant to combat inflammatory skin diseases that are prominent in today's society. Several studies have demonstrated that bioactive compounds isolated from microalgae have anti-inflammation and anti-oxidative properties that can help remedy various skin diseases. These compounds are able to inhibit production of pro-inflammatory cytokines and reduce the expression of inflammatory genes. Bioactive compounds from microalgae work in action by altering enzyme activities, regulating cellular activities, targeting major signaling pathways related to inflammation.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.